Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.

Janes MR, Zhang J, Li LS, Hansen R, Peters U, Guo X, Chen Y, Babbar A, Firdaus SJ, Darjania L, Feng J, Chen JH, Li S, Li S, Long YO, Thach C, Liu Y, Zarieh A, Ely T, Kucharski JM, Kessler LV, Wu T, Yu K, Wang Y, Yao Y, Deng X, Zarrinkar PP, Brehmer D, Dhanak D, Lorenzi MV, Hu-Lowe D, Patricelli MP, Ren P, Liu Y.

Cell. 2018 Jan 25;172(3):578-589.e17. doi: 10.1016/j.cell.2018.01.006.

2.

Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.

Patricelli MP, Janes MR, Li LS, Hansen R, Peters U, Kessler LV, Chen Y, Kucharski JM, Feng J, Ely T, Chen JH, Firdaus SJ, Babbar A, Ren P, Liu Y.

Cancer Discov. 2016 Mar;6(3):316-29. doi: 10.1158/2159-8290.CD-15-1105. Epub 2016 Jan 6.

3.

Linking root traits to nutrient foraging in arbuscular mycorrhizal trees in a temperate forest.

Eissenstat DM, Kucharski JM, Zadworny M, Adams TS, Koide RT.

New Phytol. 2015 Oct;208(1):114-24. doi: 10.1111/nph.13451. Epub 2015 May 13.

4.

Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.

So L, Yea SS, Oak JS, Lu M, Manmadhan A, Ke QH, Janes MR, Kessler LV, Kucharski JM, Li LS, Martin MB, Ren P, Jessen KA, Liu Y, Rommel C, Fruman DA.

J Biol Chem. 2013 Feb 22;288(8):5718-31. doi: 10.1074/jbc.M112.379446. Epub 2012 Dec 28.

5.

Biosynthesis of poly[(R)-3-hydroxyalkanoate] copolymers with controlled repeating unit compositions and physical properties.

Tappel RC, Kucharski JM, Mastroianni JM, Stipanovic AJ, Nomura CT.

Biomacromolecules. 2012 Sep 10;13(9):2964-72. doi: 10.1021/bm301043t. Epub 2012 Aug 17.

PMID:
22873826
6.

Tryptophol, 5-hydroxytryptophol and 5-methoxytryptophol induced sleep in mice.

Feldstein A, Chang FH, Kucharski JM.

Life Sci. 1970 Mar 15;9(6):323-9. No abstract available.

PMID:
5444013

Supplemental Content

Loading ...
Support Center